Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 236 CNY -4.49% Market Closed
Market Cap: 142.4B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Deferred Income Tax
ÂĄ22.5m
CAGR 3-Years
-21%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Deferred Income Tax
ÂĄ255m
CAGR 3-Years
28%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Deferred Income Tax
ÂĄ85.1m
CAGR 3-Years
65%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Deferred Income Tax
ÂĄ91.3m
CAGR 3-Years
-16%
CAGR 5-Years
7%
CAGR 10-Years
N/A
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Deferred Income Tax
ÂĄ25.6k
CAGR 3-Years
-65%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View

Market Cap
142.4B CNY
Industry
Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a beacon of traditional Chinese medicine, rooted in a legacy that dates back over four decades. Specializing in the production of proprietary herbal medicines, particularly its flagship product, Pientzehuang, the company expertly marries ancient healing practices with modern pharmaceutical standards. The company's commitment to quality and innovation is evident in its meticulous sourcing of raw materials and rigorous R&D efforts, positioning it as a leader in the herbal medicine sector. Zhangzhou's extensive distribution network spans both domestic and international markets, enhancing its brand recognition and further entrenching its products in the hearts and homes of patients seeking natural remedies. As the global demand for alternative healthcare solutions continues to rise, Zhangzhou Pientzehuang stands at the forefront of this burgeoning market. The company's unwavering focus on expanding its product line and leveraging e-commerce platforms provides lucrative opportunities for growth. Additionally, its strategic partnerships with healthcare institutions and researchers underscore its credibility and commitment to advancing healthcare. For investors, Zhangzhou Pientzehuang represents not merely an investment in a company, but a stake in the revival and global acceptance of traditional Chinese medicine, a field that resonates with the increasing emphasis on holistic health and wellness. With a robust business model and a future poised for expansion, the company stands as an attractive candidate for those looking to invest in the convergence of tradition and modern healthcare innovation.

Intrinsic Value
162.22 CNY
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Deferred Income Tax?
Deferred Income Tax
22.5m CNY

Based on the financial report for Jun 30, 2024, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Deferred Income Tax amounts to 22.5m CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-6%

Over the last year, the Deferred Income Tax growth was -54%. The average annual Deferred Income Tax growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been -21% over the past three years , -5% over the past five years , and -6% over the past ten years .

Back to Top